Document:

Exhibit 4.7

    

       

    RIGHTS AGREEMENT

    

       

    This Rights Agreement (this “Agreement”) is made as of __________, 2021, by and
      between bleuacacia ltd, a  Cayman Islands exempted company (the “Company”), and Continental Stock Transfer & Trust Company, a New York corporation (the “Rights Agent”).

    

       

    WHEREAS, the Company is engaged in a public offering (the “Public Offering”) of
      20,000,000 units (the “Units”) of the Company (and up to 3,000,000 additional Units if the underwriters’ over-allotment option is exercised in full), each Unit consisting of one Class A
      ordinary share of the Company, par value $0.0001 per share (the “Ordinary Shares”), one right to receive one-sixteenth of one Ordinary Share upon the happening of the triggering event
      described herein (the “Right”), and one warrant to purchase one half of an Ordinary Share (the “Warrant”);

    

       

    WHEREAS, the Company has filed with the Securities and Exchange Commission (the “SEC”)
      a Registration Statement on Form S-1, File No. 333-257240 (the “Registration Statement”), and related Prospectus (the “Prospectus”)
      for the registration, under the Securities Act of 1933, as amended (the “Act”), of, among other securities, the Rights and the Ordinary Shares issuable to the holders of the Rights;

    

       

    WHEREAS, the Company desires the Rights Agent to act on behalf of the Company, and the Rights Agent is willing to so act, in connection with
      the issuance, registration, transfer and exchange of the Rights;

    

       

    WHEREAS, the Company desires to provide for the form and provisions of the Rights, the terms upon which they shall be issued, and the
      respective rights, limitation of rights, and immunities of the Company, the Rights Agent, and the holders of the Rights; and

    

       

    WHEREAS, all acts and things have been done and performed which are necessary to make the Rights, when executed on behalf of the Company and
      countersigned by or on behalf of the Rights Agent, as provided herein, the valid, binding and legal obligations of the Company, and to authorize the execution and delivery of this Agreement.

    

       

    NOW, THEREFORE, in consideration of the mutual agreements herein contained, the parties hereto agree as follows:

    

       

    1.           Appointment of Rights Agent. The Company hereby appoints the Rights Agent to act as agent for the Company for the
      Rights, and the Rights Agent hereby accepts such appointment and agrees to perform the same in accordance with the terms and conditions set forth in this Agreement.

    

       

    2.            Rights.

    

       

    2.1         Form of Right. Each Right shall be issued in registered form only, shall be in substantially the form of Exhibit
        A hereto, the provisions of which are incorporated herein and shall be signed by, or bear the facsimile signature of, a Co-Chairman of the Board, a Co-Chief Executive Officer, the Chief Financial Officer or the Executive Director of the
      Company. In the event the person whose facsimile signature has been placed upon any Right shall have ceased to serve in the capacity in which such person signed the Right before such Right is issued, it may be issued with the same effect as if he or
      she had not ceased to be such at the date of issuance.

    

       

    2.2          Effect of Countersignature. Unless and until countersigned by the Rights Agent pursuant to this Agreement, a Right
      shall be invalid and of no effect and may not be exchanged for Ordinary Shares.

    

       

    2.3          Registration.

    

       

    2.3.1      Right Register. The Rights Agent shall maintain books (the “Right
        Register”) for the registration of original issuance and the registration of transfer of the Rights. Upon the initial issuance of the Rights, the Rights Agent shall issue and register the Rights in the names of the respective holders thereof
      in such denominations and otherwise in accordance with instructions delivered to the Rights Agent by the Company.

    

       

    
      
        

    

    
    2.3.2      Registered Holder. Prior to due presentment for registration of transfer of any Right, the Company and the Rights Agent
      may deem and treat the person in whose name such Right shall be registered upon the Right Register (the “Registered Holder”) as the absolute owner of such Right and of each Right represented
      thereby (notwithstanding any notation of ownership or other writing on the Right Certificate made by anyone other than the Company or the Rights Agent), for the purpose of the exchange thereof, and for all other purposes, and neither the Company nor
      the Rights Agent shall be affected by any notice to the contrary.

    

       

    2.4         Detachability of Rights. Each of the securities comprising the Units shall begin separate trading on
      the fifty-second (52nd) day following the date of the Prospectus or, if such fifty-second (52nd) day is not on a day other than a Saturday, Sunday or federal holiday on which banks in New York City are generally open for normal business (a “Business Day”), then on the immediately succeeding Business Day following such date, or earlier (the “Detachment Date”) with the
      consent of Credit Suisse Securities (USA) LLC and Citigroup Global Markets Inc. with the respect to such consent, but in no event shall the securities comprising the Units be separately traded until (A) the Company has filed a Current Report on Form
      8-K with the SEC containing an audited balance sheet reflecting the receipt by the Company of the gross proceeds of the Offering, including the proceeds received by the Company from the exercise by the underwriters of their right to purchase
      additional Units in the Offering (the “Over-Allotment Option”), if the Over-Allotment Option is exercised prior to the filing of such Form 8-K, and a second or amended Current Report on Form
      8-K to provide updated financial information to reflect the exercise of the underwriters’ Over-Allotment option, if the Over-Allotment option is exercised following the initial filing of such Current Report on Form 8-K, and (B) the Company issues a
      press release and files with the Commission a Current Report on Form 8-K announcing when such separate trading shall begin. Upon the Detachment Date, holders of Units will have the option to continue to hold Units or separate their Units into the
      component pieces.

    

       

    3.            Terms and Exchange of Rights

    

       

    3.1         Rights. Each Right shall entitle the holder thereof to receive one-sixteenth of one Ordinary Share upon the happening of
      an Exchange Event (defined below). No additional consideration shall be paid by a holder of Rights in order to receive his, her or its Ordinary Shares upon an Exchange Event as the purchase price for such Ordinary Shares has been included in the
      purchase price for the Units. In no event will the Company be required to net cash settle the Rights or issue fractional Ordinary Shares.

    

       

    3.2          Exchange Event. An “Exchange Event” shall occur upon the
      Company’s consummation of an initial Business Combination (as defined in the Company’s Amended and Restated Memorandum and Articles of Association).

    

       

    3.3          Exchange of Rights.

    

       

    3.3.1      Issuance of Ordinary Shares. As soon as practicable upon the occurrence of an Exchange Event, the Company shall direct
      holders of the Rights to return their Rights Certificates to the Rights Agent. Upon receipt of a valid Rights Certificate, the Company shall issue to the Registered Holder of such Right(s) the number of full Ordinary Shares to which he, she or it is
      entitled, registered in such name or names as may be directed by him, her or it and issue to such Registered Holder(s) a certificate or book-entry position for the such shares. Notwithstanding the foregoing, or any provision contained in this
      Agreement to the contrary, in no event will the Company be required to net cash settle the Rights. The Company shall not issue fractional shares upon exchange of Rights. In the event that any holder would otherwise be entitled to any fractional share
      upon exchange of Rights, at the time of an Exchange Event, the Company will instruct the Right Agent how any such entitlement will be addressed. To the fullest extent permitted by the Company’s Amended and Restated Memorandum and Articles of
      Association the Company reserves the right to deal with any such fractional entitlement at the relevant time in any manner permitted by the Act and the Amended and Restated Memorandum and Articles of Association, which would include the rounding down
      of any entitlement to receive Ordinary Shares to the nearest whole share (and in effect extinguishing any fractional entitlement), or the holder being entitled to hold any remaining fractional entitlement (without any share being issued) and to
      aggregate the same with any future fractional entitlement to receive shares in the Company until the holder is entitled to receive a whole number. Any rounding down and extinguishment may be done with or without any in lieu cash payment or other
      compensation being made to the holder of the relevant Rights, such that value received on exchange of the Rights may be considered less than the value that the holder would otherwise expect to receive.

    

       

    
      2

      
        

    

    3.3.2      Valid Issuance. All Ordinary Shares issued upon an Exchange Event in conformity with this Agreement shall be validly
      issued, fully paid and nonassessable.

    

       

    3.3.3      Date of Issuance. Each person in whose name any such certificate or book-entry position for Ordinary Shares is issued
      shall for all purposes be deemed to have become the holder of record of such shares on the date of the Exchange Event, irrespective of the date of delivery of such certificate or entry of position.

    

       

    
      
        3.3.4       Company Not
            Surviving Following Exchange Event. Upon an Exchange Event in which the Company does not continue as the publicly held reporting entity, the definitive agreement will provide for the holders of Rights to receive the same per share
          consideration the holders of the Ordinary Shares will receive in such transaction, for the number of shares such holder is entitled to pursuant to Section 3.3.1 above. If the Company does not continue as the publicly held
          reporting entity upon an Exchange Event, each holder of a Right will be required to affirmatively convert his/her or its rights in order to receive the one-sixteenth of one share underlying each right (without paying any additional consideration)
          upon consummation of the Exchange Event. In such a case, each holder of a Right will be required to indicate his, her or its election to convert the Rights into underlying Ordinary Shares as well as to return the original certificates evidencing
          the Rights to the Company.

      

    

    

       

    3.4        Duration of Rights. If an Exchange Event does not occur within the time period set forth in the
      Company’s Amended and Restated Memorandum and Articles of Association, as the same may be amended from time to time, the Rights shall expire and shall be worthless.

    

       

    4.            Transfer and Exchange of
          Rights.

    

       

    4.1        Registration of Transfer. The Rights Agent shall register the transfer, from time to time, of any outstanding Right upon
      the Right Register, upon surrender of such Right for transfer, properly endorsed with signatures properly guaranteed and accompanied by appropriate instructions for transfer. Upon any such transfer, a new Right representing an equal aggregate number
      of Rights shall be issued and the old Right shall be cancelled by the Rights Agent. The Rights so cancelled shall be delivered by the Rights Agent to the Company from time to time upon request.

    

       

    4.2         Procedure for Surrender of Rights. Rights may be surrendered to the Rights Agent, together with a written request for
      exchange or transfer, and thereupon the Rights Agent shall issue in exchange therefor one or more new Rights as requested by the Registered Holder of the Rights so surrendered, representing an equal aggregate number of Rights; provided, however, that
      in the event that a Right surrendered for transfer bears a restrictive legend and the new Rights to be issued will not bear a restrictive legend, the Rights Agent shall not cancel such Right and issue new Rights in exchange therefor until the Rights
      Agent has received an opinion of counsel for the Company stating that such transfer may be made and indicating no restrictive legend is required.

    

       

    4.3         Fractional Rights. The Rights Agent shall not be required to effect any registration of transfer or exchange which will
      result in the issuance of a Right Certificate for a fraction of a Right.

    

       

    4.4          Service Charges. No service charge shall be made for any exchange or registration of transfer of Rights.

    

       

    4.5         Adjustments to Conversion Ratios. The number of Ordinary Shares that the holders of Rights are entitled to receive as a
      result of the occurrence of an Exchange Event shall be equitably adjusted to reflect appropriately the effect of any share split, reverse share split, share dividend, reorganization, recapitalization, reclassification, combination, exchange of shares
      or other like change with respect to the Ordinary Shares occurring on or after the date hereof and prior to the Exchange Event.

    

       

    
      3

      
        

    

    4.6         Right Execution and Countersignature. The Rights Agent is hereby authorized to countersign and to deliver, in accordance
      with the terms of this Agreement, the Rights required to be issued pursuant to the provisions of this Section 4, and the Company, whenever required by the Rights Agent, will supply the Rights Agent with Rights duly executed on behalf
      of the Company for such purpose.

    

       

    5.          Other Provisions Relating to
          Rights of Holders of Rights.

    

       

    5.1         No Rights as Shareholder. Until the exchange of a Right for Ordinary Shares as provided for herein, a Right
      does not entitle the Registered Holder thereof to any of the rights of a shareholder of the Company, including, without limitation, the right to receive dividends, or other distributions, exercise any preemptive rights to vote or to consent or to
      receive notice as shareholders in respect of the meetings of shareholders or the election of directors of the Company or any other matter.

    

       

    5.2         Lost, Stolen, Mutilated, or Destroyed Rights. If any
      Right is lost, stolen, mutilated, or destroyed, the Company and the Rights Agent may on such terms as to indemnity or otherwise as they may in their discretion impose (which shall, in the case of a mutilated Right, include the surrender thereof),
      issue a new Right of like denomination, tenor, and date as the Right so lost, stolen, mutilated, or destroyed. Any such new Right shall constitute a substitute contractual obligation of the Company, whether or not the allegedly lost, stolen,
      mutilated, or destroyed Right shall be at any time enforceable by anyone.

    

       

    5.3          Reservation of Ordinary Shares. The Company shall at all times reserve and keep available a number of its
      authorized but unissued Ordinary Shares that will be sufficient to permit the exchange of all outstanding Rights issued pursuant to this Agreement.

    

       

    6.          Concerning the Rights Agent and
          Other Matters.

    

       

    6.1          Payment of Taxes. The Company will from time to time promptly pay all taxes and charges that
      may be imposed upon the Company or the Rights Agent in respect of the issuance or delivery of Ordinary Shares upon the exchange of Rights, but the Company shall not be obligated to pay any transfer taxes in respect of the Rights or such Ordinary
      Shares.

    

       

    6.2          Resignation, Consolidation, or
          Merger of Rights Agent.

    

       

    6.2.1      Appointment of Successor Rights Agent. The Rights Agent, or any successor to it hereafter appointed, may resign its
      duties and be discharged from all further duties and liabilities hereunder after giving sixty (60) days’ notice in writing to the Company. If the office of the Rights Agent becomes vacant by resignation or incapacity to act or otherwise, the Company
      shall appoint in writing a successor Rights Agent in place of the Rights Agent. If the Company shall fail to make such appointment within a period of 30 days after it has been notified in writing of such resignation or incapacity by the Rights Agent
      or by the holder of the Right (who shall, with such notice, submit his, her or its Right for inspection by the Company), then the holder of any Right may apply to the Supreme Court of the State of New York for the County of New York for the
      appointment of a successor Rights Agent at the Company’s cost. Any successor Rights Agent, whether appointed by the Company or by such court, shall be a corporation organized and existing under the laws of the State of New York, in good standing and
      having its principal office in the Borough of Manhattan, City and State of New York, and authorized under such laws to exercise corporate trust powers and subject to supervision or examination by federal or state authority. After appointment, any
      successor Rights Agent shall be vested with all the authority, powers, rights, immunities, duties, and obligations of its predecessor Rights Agent with like effect as if originally named as Rights Agent hereunder, without any further act or deed; but
      if for any reason it becomes necessary or appropriate, the predecessor Rights Agent shall execute and deliver, at the expense of the Company, an instrument transferring to such successor Rights Agent all the authority, powers, and rights of such
      predecessor Rights Agent hereunder; and upon request of any successor Rights Agent the Company shall make, execute, acknowledge, and deliver any and all instruments in writing for more fully and effectually vesting in and confirming to such successor
      Rights Agent all such authority, powers, rights, immunities, duties, and obligations.

    

       

    
      4

      
        

    

    6.2.2      Notice of Successor Rights Agent. In the event a successor Rights Agent shall be appointed, the Company shall give notice
      thereof to the predecessor Rights Agent and the transfer agent for the Ordinary Shares not later than the effective date of any such appointment.

    

       

    6.2.3      Merger or Consolidation of Rights Agent. Any corporation into which the Rights Agent may be merged or with which it may
      be consolidated or any corporation resulting from any merger or consolidation to which the Rights Agent shall be a party shall be the successor Rights Agent under this Agreement without any further act.

    

       

    
      
        6.3          Fees and Expenses of Rights Agent.

      

    

    

       

    6.3.1      Remuneration. The Company agrees to pay the Rights Agent reasonable remuneration for its services as such Rights Agent
      hereunder and will reimburse the Rights Agent upon demand for all expenditures that the Rights Agent may reasonably incur in the execution of its duties hereunder.

    

       

    6.3.2      Further Assurances. The Company agrees to perform, execute, acknowledge, and deliver or cause to be performed, executed,
      acknowledged, and delivered all such further and other acts, instruments, and assurances as may reasonably be required by the Rights Agent for the carrying out or performing of the provisions of this Agreement.

    

       

    6.4          Liability of Rights Agent.

    

       

    6.4.1     Reliance on Company Statement. Whenever in the performance of its duties under this Agreement, the Rights Agent shall
      deem it necessary or desirable that any fact or matter be proved or established by the Company prior to taking or suffering any action hereunder, such fact or matter (unless other evidence in respect thereof be herein specifically prescribed) may be
      deemed to be conclusively proved and established by a statement signed by the Chief Executive Officer or Chief Financial Officer and delivered to the Rights Agent. The Rights Agent may rely upon such statement for any action taken or suffered in good
      faith by it pursuant to the provisions of this Agreement.

    

       

    6.4.2      Indemnity. The Rights Agent shall be liable hereunder only for its own gross negligence, willful misconduct or bad
      faith. Subject to Section 6.6 below, the Company agrees to indemnify the Rights Agent and save it harmless against any and all liabilities, including judgments, costs and reasonable counsel fees, for anything done or omitted by the
      Rights Agent in the execution of this Agreement except as a result of the Rights Agent’s gross negligence, willful misconduct, or bad faith.

    

       

    6.4.3     Exclusions. The Rights Agent shall have no responsibility with respect to the validity of this Agreement or with respect
      to the validity or execution of any Right (except its countersignature thereof); nor shall it be responsible for any breach by the Company of any covenant or condition contained in this Agreement or in any Right; nor shall it by any act hereunder be
      deemed to make any representation or warranty as to the authorization or reservation of any Ordinary Shares to be issued pursuant to this Agreement or any Right or as to whether any Ordinary Shares will when issued be valid and fully paid and
      nonassessable.

    

       

    6.5          Acceptance of Agency. The Rights Agent hereby accepts the agency established by this Agreement and agrees to perform
      the same upon the terms and conditions herein set forth.

    

       

    6.6         Waiver. The Rights Agent hereby waives any right of set-off or any other right, title, interest or claim of any kind (“Claim”) in, or to any distribution of, the Trust Account (as defined in that certain Investment Management Trust Agreement, dated as of the date hereof, by and between the Company and the Rights
      Agent as trustee thereunder) and hereby agrees not to seek recourse, reimbursement, payment or satisfaction for any Claim against the Trust Account for any reason whatsoever.

    

       

    
      5

      
        

    

    7.           Miscellaneous Provisions.

    

       

    7.1          Successors. All the covenants and provisions of this Agreement by or for the benefit of the Company or the Rights Agent
      shall bind and inure to the benefit of their respective successors and assigns.

    

       

    7.2         Notices. Any notice, statement or demand authorized by this Agreement to be given or made by the Rights Agent or by the
      holder of any Right to or on the Company shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five days after deposit of such notice, postage prepaid, addressed
      (until another address is filed in writing by the Company with the Rights Agent), as follows:

    

       

    bleuacacia ltd

    500 Fifth Avenue

    New York, New York 10110

    Attention: Co-Chief Executive Officers

    

       

    with a copy (which shall not constitute notice) to:

    

       

    Freshfields Bruckhaus Deringer US LLP

    601 Lexington Avenue

    New York, New York 10022

    Attention: Valerie Ford Jacob, Esq.

    Email: valerie.jacob@freshfields.com

    

       

    Any notice, statement or demand authorized by this Agreement to be given or made by the holder of any Right or by the Company to or on the
      Rights Agent shall be sufficiently given when so delivered if by hand or overnight delivery or if sent by certified mail or private courier service within five days after deposit of such notice, postage prepaid, addressed (until another address is
      filed in writing by the Rights Agent with the Company), as follows:

    

       

    Continental Stock Transfer & Trust Company

    One State Street, 30th Floor

    New York, New York 10004

    Attn: Compliance Department

    

       

    in each case, with a copy to:

    

       

    [●]

    

       

    7.3          Applicable Law and Exclusive Forum. The validity, interpretation, and performance of this Agreement and of the Rights
      shall be governed in all respects by the laws of the State of New York, without giving effect to conflict of laws. Subject to applicable law, the Company and the Rights Agent hereby agree that any action, proceeding or claim against either of them
      arising out of or relating in any way to this Agreement shall be brought and enforced in the courts of the State of New York or the United States District Court for the Southern District of New York, and irrevocably submits to such jurisdiction,
      which jurisdiction shall be exclusive forum for any such action, proceeding or claim. The Company and the Rights Agent hereby waive any objection to such exclusive jurisdiction and that such courts represent an inconvenient forum. Notwithstanding the
      foregoing, the provisions of this paragraph will not apply to suits brought to enforce any liability or duty created by the Securities Exchange Act of 1934, as amended (the “Exchange Act”),
      any other claim for which the federal district courts of the United States of America are the sole and exclusive forum, or any complaint asserting a cause of action arising under the Act against us or any of our directors, officers, other employees
      or agents. Section 27 of the Exchange Act creates exclusive federal jurisdiction over all suits brought to enforce any duty or liability created by the Exchange Act or the rules and regulations thereunder.

    

       

    
      6

      
        

    

    Any person or entity purchasing or otherwise acquiring any interest in the Rights shall be deemed to have notice of and to have consented to
      the forum provisions in this Section 7.3. If any action, the subject matter of which is within the scope the forum provisions above, is filed in a court other than a court located within the State of New York or the United States
      District Court for the Southern District of New York (a “foreign action”) in the name of any Rights holder, such Rights holder shall be deemed to have consented to: (x) the personal
      jurisdiction of the state and federal courts located within the State of New York or the United States District Court for the Southern District of New York in connection with any action brought in any such court to enforce the forum provisions (an “enforcement action”), and (y) having service of process made upon such Rights holder in any such enforcement action by service upon such Rights holder’s counsel in the foreign action as agent
      for such Rights holder.

    

       

    7.4         Persons Having Rights under this Agreement. Nothing in this Agreement expressed and nothing that may be implied from any
      of the provisions hereof is intended, or shall be construed, to confer upon, or give to, any person or corporation other than the parties hereto and the Registered Holders of the Rights and any right, remedy, or claim under or by reason of this
      Agreement or of any covenant, condition, stipulation, promise, or agreement hereof. All covenants, conditions, stipulations, promises, and agreements contained in this Agreement shall be for the sole and exclusive benefit of the parties hereto and
      their successors and assigns and of the Registered Holders of the Rights.

    

       

    7.5          Examination of the Right Agreement. A copy of this Agreement shall be available at all reasonable times at the office
      of the Rights Agent in the Borough of Manhattan, City and State of New York, for inspection by the Registered Holder of any Right. The Rights Agent may require any such holder to submit his, her or its Right for inspection by it.

    

       

    7.6         Counterparts. This Agreement may be executed in any number of original or facsimile counterparts and each of such
      counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

    

       

    7.7          Effect of Headings. The Section headings herein are for convenience only and are not part of this Agreement and shall
      not affect the interpretation thereof.

    

       

    7.8         Amendments. This Agreement may be amended by the parties hereto without the consent of any Registered Holder for the
      purpose of curing any ambiguity, or of curing, correcting or supplementing any defective provision contained herein or adding or changing any other provisions with respect to matters or questions arising under this Agreement as the parties may deem
      necessary or desirable and that the parties deem shall not adversely affect the interest of the Registered Holders. All other modifications or amendments shall require the written consent or vote of the Registered Holders of a majority of the then
      outstanding Rights.

    

       

    7.9         Severability. This Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision
      hereof shall not affect the validity or enforceability of this Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a
      part of this Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

    

       

    [Signature Page Follows]

    

       

    
      7

      
        

    

    IN WITNESS WHEREOF, this Agreement has been duly executed by the parties hereto as of the day and year first above written.

    

       

    

       

    	 	
            BLEUACACIA LTD

          
	 	
            By:

          	 	 
	 	 	
            Name:

          	 
	 	 	
            Title:

          	 

    

       

    

    
      	 	
              CONTINENTAL STOCK TRANSFER & TRUST COMPANY

            
	 	
              By:

            	 	 
	 	 	
              Name:

            	 
	
               

            	 	
              Title:

            	 

    

    

       

    

      [Signature Page to Rights Agreement]Exhibit 10.2

  bleuacacia ltd

  500 Fifth Avenue

  New York, New York 10110

    

  

  	
          Re:

        	
          Initial Public Offering

        

   

  Ladies and Gentlemen:

   

  This letter (this “Letter Agreement”) is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting

          Agreement”) entered into or proposed to be entered into by and between bleuacacia ltd, a Cayman Islands exempted company (the “Company”), and Credit Suisse Securities (USA) LLC and Citigroup Global Markets Inc.,
    as the representatives of the several underwriters named therein (the “Underwriters”), relating to an underwritten initial public offering (the “Public Offering”), of 23,000,000 of the Company’s units
    (including up to 3,000,000 units that may be purchased to cover over-allotments, if any) (the “Units”), each comprised of one Class A ordinary share, par value $0.0001 per share (each, an “Ordinary Share”) of
    the Company, one right to receive one-sixteenth of one Ordinary Share, and one-half of one redeemable warrant (each whole warrant, a “Warrant”). Each Warrant entitles the holder thereof to purchase one Ordinary Share at a price of
    $11.50 per share, subject to adjustment. The Units shall be sold in the Public Offering pursuant to a registration statement on Form S-1 and a prospectus (the “Prospectus”) filed by the Company with the Securities and Exchange
    Commission (the “Commission”). Certain capitalized terms used herein are defined in paragraph 12 hereof.

    

  

  In order to induce the Company and the Underwriters to enter into the Underwriting Agreement and to proceed with the Public Offering and for other
    good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, bleuacacia sponsor LLC, a Cayman Islands limited liability company (the “Sponsor”), and the other undersigned persons (each, an “Insider”
    and collectively, the “Insiders”), hereby agrees with the Company as follows:

   

  1. The Sponsor and each Insider agrees with the Company that if the Company seeks shareholder approval of a proposed Business Combination, then in
    connection with such proposed Business Combination, it, he or she shall (i) vote any Shares owned by it, him or her in favor of any proposed Business Combination (including any proposals recommended by the Company’s Board of Directors in connection
    with such Business Combination) and (ii) not redeem any Shares owned by it, him or her in connection with such shareholder approval or sell or tender any Shares if the Company seeks to consummate a Business Combination by engaging in a tender offer.

   

  2. The Sponsor and each Insider hereby agrees with the Company that in the event that the Company fails to consummate a Business Combination
    within 18 months from the closing of the Public Offering, or such later period approved by the Company’s shareholders in accordance with the Company’s amended and restated memorandum and articles of association, as they may be amended from time to
    time, the Sponsor and each Insider shall take all reasonable steps to cause the Company to (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten (10) business days thereafter,
    redeem 100% of the Ordinary Shares sold as part of the Units in the Public Offering (the “Offering Shares”), at a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including
    interest (less up to $100,000 of interest to pay dissolution expenses and which interest shall be net of taxes payable), divided by the number of then issued and outstanding Offering Shares, which redemption will completely extinguish all Public
    Shareholders’ rights as shareholders (including the right to receive further liquidation distributions, if any), and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining shareholders and
    the Company’s Board of Directors, liquidate and dissolve, subject in each case to the Company’s obligations under Cayman Islands law to provide for claims of creditors and the requirements of other applicable law. The Sponsor and each Insider agrees to
    not propose any amendment to the Company’s amended and restated memorandum and articles of association (i) to modify the substance or timing of the Company’s obligation to allow redemption in connection with the Company’s initial Business Combination
    or to redeem 100% of the Offering Shares if the Company does not complete its initial Business Combination within 18 months from the closing of the Public Offering, or (ii) with respect to any other provision relating to shareholders’ rights or
    pre-initial Business Combination activity, unless the Company provides its Public Shareholders with the opportunity to redeem their Offering Shares upon approval of any such amendment at a per share price, payable in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of taxes payable), divided by the number of then issued and outstanding Offering Shares.

  
  
    

  

  
     

  

  
   

  The Sponsor and each Insider acknowledges that it, he or she has no right, title, interest or claim of any kind in or to any monies held in the
    Trust Account or any other asset of the Company as a result of any liquidation of the Company with respect to the Founder Shares held by it, him or her. The Sponsor and each Insider hereby further waives, with respect to any Shares held by it, him or
    her, if any, any redemption rights it, he or she may have in connection with (x) the consummation of a Business Combination, including, without limitation, any such rights available in the context of a shareholder vote to approve such Business
    Combination or in the context of a tender offer made by the Company to purchase Ordinary Shares and (y) a shareholder vote to amend the Company’s amended and restated memorandum and articles of association (i) to modify the substance or timing of the
    Company’s obligation to allow redemption in connection with the Company’s initial Business Combination or to redeem 100% of the Offering Shares if the Company does not complete its initial Business Combination within 18 months from the closing of the
    Public Offering, or (ii) with respect to any other provision relating to shareholders’ rights or pre-initial Business Combination activity (although the Sponsor and the Insiders shall be entitled to redemption and liquidation rights with respect to any
    Offering Shares it or they hold if the Company fails to consummate a Business Combination within the time period set forth in the Company’s amended and restated memorandum and articles of association).

    

  

  3. Notwithstanding the provisions set forth in paragraphs 8(a) and (b) below, during the period commencing on the effective date of the
    Underwriting Agreement and ending 180 days after such date, the Sponsor and each Insider shall not, without the prior written consent of Credit Suisse Securities (USA) LLC and Citigroup Global Markets Inc., offer, sell, contract to sell, pledge or
    otherwise dispose of (or enter into any transaction that is designed to, or might reasonably be expected to, result in the disposition (whether by actual disposition or effective economic disposition due to cash settlement or otherwise)), directly or
    indirectly, or establish or increase a put equivalent position or liquidate or decrease a call equivalent position within the meaning of Section 16 (“Section 16”) of the Securities Exchange Act of 1934, as amended, and the rules
    and regulations of the Commission promulgated thereunder (the “Exchange Act”), with respect to, any Units, Rights, Shares, Warrants, Private Placement Warrants or any securities convertible
    into, or exercisable, or exchangeable for, Ordinary Shares, or publicly announce an intention to effect any such transaction; provided, however, that the foregoing does not apply to the forfeiture of any Founder Shares pursuant to their
    terms or any transfer of Founder Shares to any current or future independent director of the company (as long as such current or future independent director transferee is subject to this Letter Agreement or executes an agreement substantially identical
    to the terms of this Letter Agreement, as applicable to directors and officers at the time of such transfer; and as long as, to the extent any Section 16 reporting obligation is triggered as a result of such transfer, any related Section 16 filing
    includes a practical explanation as to the nature of the transfer). The provisions of this paragraph will not apply if the release or waiver is effected solely to permit a transfer not for consideration and the transferee has agreed in writing to be
    bound by the same terms described in this Letter Agreement to the extent and for the duration that such terms remain in effect at the time of the transfer.

   

  4. In the event of the liquidation of the Trust Account, the Sponsor (which for purposes of clarification shall not extend to any other
    shareholders, members or managers of the Sponsor) agrees to indemnify and hold harmless the Company against any and all loss, liability, claim, damage and expense whatsoever (including, but not limited to, any and all legal or other expenses reasonably
    incurred in investigating, preparing or defending against any litigation, whether pending or threatened, or any claim whatsoever) to which the Company may become subject as a result of any claim by (i) any third party for services rendered (other than
    the Company’s independent registered public accountants) or products sold to the Company or (ii) a prospective target business with which the Company has discussed entering into a transaction agreement (a “Target”); provided,
    however, that such indemnification of the Company by the Sponsor shall apply only to the extent necessary to ensure that such claims by a third party for services rendered (other than the Company’s independent registered public accountants) or
    products sold to the Company or a Target do not reduce the amount of funds in the Trust Account to below (i) $10.00 per Offering Share or (ii) such lesser amount per Offering Share held in the Trust Account as of the date of the liquidation of the
    Trust Account due to reductions in the value of the trust assets, in each case, net of the amount of interest earned on the property in the Trust Account which may be withdrawn to pay taxes, except as to any claims by a third party who executed a
    waiver of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the Underwriters against certain liabilities, including liabilities under the Securities Act of 1933, as amended. In the event
    that any such executed waiver is deemed to be unenforceable against such third party, the Sponsor shall not be responsible to the extent of any liability for such third party claims. The Sponsor shall have the right to
      defend against any such claim with counsel of its choice reasonably satisfactory to the Company if, within 15 days following written receipt of notice of the claim to the Sponsor, the Sponsor notifies the Company in writing that it shall undertake
      such defense.

  
  
    

  

  
     

  

  
   

  5. To the extent that the Underwriters do not exercise their over-allotment option to purchase up to an additional 3,000,000 Units within 45 days
    from the date of the Prospectus (and as further described in the Prospectus), the Initial Shareholders agree to forfeit, at no cost, a number of Founder Shares in the aggregate equal to 750,000 multiplied by a fraction, (i) the numerator of which is
    3,000,000 minus the number of Units purchased by the Underwriters upon the exercise of their over-allotment option, and (ii) the denominator of which is 3,000,000. All references (not including Ordinary Shares underlying the Private Placement Warrants)
    in this Letter Agreement to Founder Shares of the Company being forfeited shall take effect as surrenders for no consideration of such Founder Shares as a matter of Cayman Islands law. The forfeiture will be adjusted to the extent that the
    over-allotment option is not exercised in full by the Underwriters so that the number of Founder Shares will equal an aggregate of 20.0% of the Company’s issued and outstanding Shares after the Public Offering (not including Ordinary Shares underlying
    the Private Placement Warrants). The Initial Shareholders further agree that to the extent that the size of the Public Offering is increased or decreased, the Company will effect a capitalization or share repurchase or redemption, as applicable,
    immediately prior to the consummation of the Public Offering in such amount as to maintain the number of Founder Shares at 20.0% of the Company’s issued and outstanding Shares upon the consummation of the Public Offering. In connection with such
    increase or decrease in the size of the Public Offering, then (A) the references to 3,000,000 in the numerator and denominator of the formula in the first sentence of this paragraph shall be changed to a number equal to 15% of the number of Ordinary
    Shares included in the Units issued in the Public Offering and (B) the reference to 750,000 in the formula set forth in the immediately preceding sentence shall be adjusted to such number of Founder Shares that the Initial Shareholders would have to
    return to the Company in order for the number of Founder Shares to equal an aggregate of 20.0% of the Company’s issued and outstanding Shares after the Public Offering (not including the Ordinary Shares underlying the Warrants or Private Placement
    Warrants).

   

  6. The Sponsor and each Insider hereby agrees and acknowledges that: (i) the Underwriters and the Company would be irreparably injured in the
    event of a breach by such Sponsor or Insider of its, his or her obligations under paragraphs 1, 2, 3, 4, 5, 8(a), 8(b), and 10 of this Letter Agreement, (ii) monetary damages may not be an adequate remedy for such breach and (iii) the non-breaching
    party shall be entitled to seek injunctive relief, in addition to any other remedy that such party may have in law or in equity, in the event of such breach.

   

   7. (a) The Sponsor agrees that upon and subject to the completion of the Business Combination (the “Business Combination Closing”), 25% of the Founder Shares then held by the Sponsor shall be considered to be newly unvested shares, one-half of which (or 12.5%
    of the Founder Shares then held by the Sponsor) shall vest only if the First Share Price Level (as defined below) is achieved on or after the first anniversary of the Business Combination Closing but before the fifth anniversary of the Business
    Combination Closing; and one-half of which (or 12.5% of the Founder Shares then held by the Sponsor) shall vest only if the Second Share Price Level (as defined below) is achieved on or after the first anniversary of the Business Combination Closing
    but before the fifth anniversary of the Business Combination Closing. 

  

   

  

  (b) The Sponsor agrees that it shall not Transfer any unvested Founder Shares prior to the date such Founder Shares become vested, except to
    the extent permitted by paragraph 8(c). 

  

   

  

  (c) Founder Shares, if any, that remain unvested at the fifth anniversary of the Business Combination Closing will be forfeited, and shall be
    transferred by the Sponsor to the Company without any consideration for such transfer. For the avoidance of doubt, the Founder Shares owned by the individual Insiders other than the Sponsor shall not be subject to vesting or forfeiture. 

  

   

  

   (d) For purposes of this paragraph 7, the “First Share Price Level” will be
    considered achieved only if the closing price of the Ordinary Shares on the New York Stock Exchange (or other exchange or other market where the Ordinary Shares are then traded) equals or exceeds $12.50 for any 20 trading days within a 30 trading day
    period on or after the first anniversary of the Business Combination Closing but before the fifth anniversary of the Business Combination Closing; and the “Second Share Price Level” will be
    considered achieved only if the closing price of the Ordinary Shares on the New York Stock Exchange (or other exchange or other market where the Ordinary Shares are then traded) equals or exceeds $15.00 for any 20 trading days within a 30 trading day
    period on or after the first anniversary of the Business Combination Closing but before the fifth anniversary of the Business Combination Closing. The First Share Price Level and Second Share Price Level will be equitably adjusted on account of any
    share split, reverse share split or similar equity restructuring transaction. 

  

   

  

   (e) Notwithstanding the foregoing, in the event the Company enters into a binding agreement on or before the fifth anniversary of the Business
    Combination Closing with respect to a Sale (as defined below), all unvested Founder Shares shall vest on the day prior to the closing of such Sale. “Sale” shall mean the occurrence of any of
    the following events (which, for the avoidance of doubt, shall not include the Business Combination): (a) any person or any group of persons acting together which would constitute a “group” for purposes of Section 13(d) of the Exchange Act or any
    successor provisions thereto is or becomes the beneficial owner, directly or indirectly, of securities of the Company representing more than 50% of the combined voting power of the Company’s then outstanding voting securities, (b) there is consummated
    a merger or consolidation of the Company with any other corporation or other entity, and, immediately after the consummation of such merger or consolidation, either (x) the board of directors of the Company immediately prior to the merger or
    consolidation does not constitute at least a majority of the board of directors of the company surviving the merger or, if the surviving company is a subsidiary, the ultimate parent thereof, or (y) the voting securities of the Company immediately prior
    to such merger or consolidation do not continue to represent or are not converted into more than 50% of the combined voting power of the then outstanding voting securities of the person resulting from such merger or consolidation or, if the surviving
    company is a subsidiary, the ultimate parent thereof, or (c) the shareholders of the Company approve a plan of complete liquidation or dissolution of the Company or there is consummated an agreement or series of related agreements for the sale, lease
    or other disposition, directly or indirectly, by the Company of all or substantially all of the assets of the Company and its subsidiaries, taken as a whole, other than such sale or other disposition by the Company of all or substantially all of the
    assets of the Company and its Subsidiaries, taken as a whole, to an entity at least 50% of the combined voting power of the voting securities of which are owned by shareholders of the Company in substantially the same proportions as their ownership of
    the Company immediately prior to such sale.  

  

   

  

  8. (a) The Sponsor and each Insider agrees that it, he or she shall not Transfer (as defined below) any Founder Shares (or Ordinary Shares
    issuable upon conversion thereof) until the earlier of (A) one year after the completion of the Company’s initial Business Combination and (B) subsequent to the Business Combination, (x) if the last reported sale price of the Ordinary Shares equals or
    exceeds $12.00 per share (as adjusted for share sub-divisions, share dividends, rights issuances, consolidations, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing at least 150 days
    after the Company’s initial Business Combination or (y) the date on which the Company completes a liquidation, merger, share exchange, reorganization or other similar transaction that results in all of the Company’s Public Shareholders having the right
    to exchange their Ordinary Shares for cash, securities or other property (the “Founder Shares Lock-up Period”).

   

  (b) The Sponsor and each Insider agrees that it, he or she shall not Transfer any Private Placement Warrants (or Ordinary Shares issued or
    issuable upon the exercise or conversion of the Private Placement Warrants), until 30 days after the completion of a Business Combination (the “Private Placement Warrants Lock-up Period”, together with the Founder Shares Lock-up
    Period, the “Lock-up Periods”).

  
  
    

  

  
     

  

  
   

  (c) Notwithstanding the provisions set forth in paragraphs 7(b), 8(a) and 8(b), transfers of the Founder Shares, Private Placement Warrants and
    Ordinary Shares issued or issuable upon the exercise or conversion of the Private Placement Warrants or the Founder Shares, are permitted (a) to the Company’s directors or officers, any affiliates or family members of the Company’s directors or
    officers, the Sponsor, any members of the Sponsor or any affiliates of the Sponsor; (b) in the case of an individual, by gift to a member of the individual’s immediate family, or to a trust, the beneficiary of which is a member of the individual’s
    immediate family or an affiliate of such person, or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an
      individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with the consummation of the Company’s Business Combination at prices no greater than the price at which the securities were originally
      purchased; (f) in the event of the Company’s liquidation prior to the Company’s completion of an initial Business Combination; (g) in the case of an entity, by virtue of the laws of its jurisdiction or its organizational documents or operating
      agreement; and (h) in the event of the Company’s completion of a liquidation, merger, share exchange, reorganization or other similar transaction which results in all of the Company’s shareholders having the right to exchange their Ordinary Shares
      for cash, securities or other property subsequent to the completion of the Company’s initial Business Combination; provided, however, that, in the case of clauses (a) through (e), these permitted transferees must enter into a written agreement with the Company agreeing to be bound by the transfer restrictions in this Agreement.

   

  9. The Sponsor and each Insider represents and warrants that it, he or she has never been suspended or expelled from membership in any securities
    or commodities exchange or association or had a securities or commodities license or registration denied, suspended or revoked. Each Insider’s biographical information furnished to the Company, if any (including any such information included in the
    Prospectus), is true and accurate in all respects and does not omit any material information with respect to such Insider’s background. The Sponsor and each Insider’s questionnaire(s) furnished to the Company, if any, is true and accurate in all
    respects. The Sponsor and each Insider represents and warrants that: it, he or she is not subject to or a respondent in any legal action for, any injunction, cease-and-desist order or order or stipulation to desist or refrain from any act or practice
    relating to the offering of securities in any jurisdiction; it, he or she has never been convicted of, or pleaded guilty to, any crime (i) involving fraud, (ii) relating to any financial transaction or handling of funds of another person, or (iii)
    pertaining to any dealings in any securities; and it, he or she is not currently a defendant in any such criminal proceeding.

   

  10. Except as disclosed in, or as expressly contemplated by, the Prospectus, neither the Sponsor nor any Insider nor any affiliate of the Sponsor
    or any Insider, nor any director or officer of the Company, shall receive from the Company any finder’s fee, reimbursement, consulting fee, monies in respect of any repayment of a loan or other compensation prior to, or in connection with any services
    rendered in order to effectuate the consummation of the Company’s initial Business Combination (regardless of the type of transaction that it is).

   

  11. The Sponsor and each Insider has full right and power, without violating any agreement to which it is bound (including, without limitation,
    any non-competition or non-solicitation agreement with any employer or former employer), to enter into this Letter Agreement and, as applicable, to serve as an officer and/or a director on the board of directors of the Company and hereby consents to
    being named in the Prospectus as an officer and/or a director of the Company.

   

  12. As used herein, (i) “Business Combination” shall mean a merger, share exchange, asset acquisition, share purchase,
    reorganization or similar business combination, involving the Company and one or more businesses; (ii) “Shares” shall mean, collectively, the Ordinary Shares and the Founder Shares; (iii) “Founder Shares” shall
    mean the 5,750,000 Class B Ordinary Shares, par value $0.0001 per share, issued and outstanding immediately prior to the consummation of the Public Offering; (iv) “Initial Shareholders” shall mean the Sponsor and any other person
    that holds Founder Shares; (v) “Private Placement Warrants” shall mean the warrants to purchase an aggregate of 6,000,000 Ordinary Shares of the Company (or up to 6,600,000 Ordinary Shares of the Company depending on the extent to
    which the Underwriters’ over-allotment option is exercised pursuant to the Underwriting Agreement) that the Sponsor has agreed to purchase for an aggregate purchase price of $6,000,000 (or up to $6,600,000 depending on the extent to which the
    Underwriters’ over-allotment option is exercised pursuant to the Underwriting Agreement), or $1.00 per Warrant, in a private placement that shall occur simultaneously with the consummation of the Public Offering; (vi) “Public Shareholders”
    shall mean the holders of securities issued in the Public Offering; (vii) “Trust Account” shall mean the trust fund into which a portion of the net proceeds of the Public Offering and the sale of the Private Placement Warrants
    shall be deposited; and (viii) “Transfer” shall mean the (a) sale of, offer to sell, contract or agreement to sell, hypothecate, pledge, grant of any option to purchase or otherwise dispose of or agreement to dispose of, directly
    or indirectly, or establishment or increase of a put equivalent position or liquidation with respect to or decrease of a call equivalent position within the meaning of Section 16 of the Exchange Act, (b) entry into any swap or other arrangement that
    transfers to another, in whole or in part, any of the economic consequences of ownership of any security, whether any such transaction is to be settled by delivery of such securities, in cash or otherwise, or (c) public announcement of any intention to
    effect any transaction specified in clause (a) or (b).

  
   

   

  
  13. This Letter Agreement constitutes the entire agreement and understanding of the parties hereto in respect of the subject matter hereof and
    supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby. This Letter Agreement may
    not be changed, amended, modified or waived (other than to correct a typographical error) as to any particular provision, except by a written instrument executed by (1) each Insider that is the subject of any such change, amendment, modification or
    waiver and (2) the Sponsor.

   

  14. No party hereto may assign either this Letter Agreement or any of its rights, interests, or obligations hereunder without the prior written
    consent of the other parties. Any purported assignment in violation of this paragraph shall be void and ineffectual and shall not operate to transfer or assign any interest or title to the purported assignee. This Letter Agreement shall be binding on
    the Sponsor and each Insider and their respective successors, heirs and assigns and permitted transferees.

   

  15. This Letter Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York. The parties hereto
    (i) all agree that any action, proceeding, claim or dispute arising out of, or relating in any way to, this Letter Agreement shall be brought and enforced in the courts of New York City, in the State of New York, and irrevocably submit to such
    jurisdiction and venue, which jurisdiction and venue shall be exclusive and (ii) waive any objection to such exclusive jurisdiction and venue or that such courts represent an inconvenient forum.

   

  16. Any notice, consent or request to be given in connection with any of the terms or provisions of this Letter Agreement shall be in writing and
    shall be sent by express mail or similar private courier service, by certified mail (return receipt requested), by hand delivery or facsimile or other electronic transmission.

    

  

  17. Each party hereto shall not be liable for any breaches or misrepresentations contained in this Letter Agreement by any other party to this
    Letter Agreement (including, for the avoidance of doubt, any Insider with respect to any other Insider), and no party shall be liable or responsible for the obligations of another party, including, without limitation, indemnification obligations and
    notice obligations.

   

  18. This Letter Agreement shall terminate on the earlier of (i) the expiration of the Lock-up Periods and (ii) the liquidation of the Company; provided,
    however, that this Letter Agreement shall earlier terminate in the event that the Public Offering is not consummated and closed by January 31, 2022; provided further that paragraph 4 of this Letter Agreement shall survive such
    liquidation.

   

  19. This Letter Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts shall for all purposes
    be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

   

  20. This Letter Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the
    validity or enforceability of this Letter Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Letter
    Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

   

  [Signature page follows]

  
   

   

  
  	
           

        	
          Sincerely,

        
	
           

        	
          BLEUACACIA SPONSOR LLC

        
	
           

        	
          By:

        	
           

        
	
           

        	
           

        	
          Name: Jide Zeitlin

        
	
           

        	
           

        	
          Title: Co-Chief Executive Officer

        

   

  	 	 
	 	Name: Jide Zeitlin
	 	Title: Co-Chairman and Co-Chief Executive Officer

          

   

  	
           

        	
           

        
	
           

        	
          Name: Lew Frankfort

        
	
           

        	
          Title: Co-Chairman and Co-Chief Executive Officer

        

   

  	
           

        	
           

        
	
           

        	
          Name: Charles McGuigan

        
	
           

        	
          Title: Chief Operating Officer, President and Director

          

        

   

  	
           

        	
           

        
	
           

        	
          Name: Thomas Northover

        
	
           

        	
          Title: Executive Director

          

        

   

  	
           

        	
           

        
	
           

        	
          Name: Natara Holloway

        
	
           

        	
          Title: Director

        

   

  	
           

        	
           

        
	
           

        	
          Name: Ibukun Awosika

        
	
           

        	
          Title: Director

        

   

  
   

   

  
  Acknowledged and Agreed:

  	
          BLEUACACIA LTD

        	
           

        
	
          By:

        	
           

        	
           

        
	
           

        	
          Name: Jide Zeitlin

        	
           

        
	
           

        	
          Title:   Co-Chief Executive Officer

        	
           

        

   

  	
          By:

        	
           

        	
           

        
	
           

        	
          Name: Lew Frankfort

        	
           

        
	
           

        	
          Title:   Co-Chief Executive Officer

        	
           

        

   

  [Signature Page to Letter Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00335-of-00352.parquet"}]]